IRVINE, Calif., June 23 Cardiogenesis Corporation (OTCQB: CGCP), today announced that it is scheduled to present at the New York OneMedForum Emerging Company Finance Conference to be held June 29-30, 2010 at the Roosevelt Hotel. Executive Chairman Paul J. McCormick will present a corporate overview on Wednesday, June 30, 2010 at 9:40 am Eastern Time (6:40 am Pacific Time) and meet one-on-one with investors during the conference. The presentation and a link to the live video webcast at will be available at www.cardiogenesis.com; click on investors. The webcast will also be available at www.onemedplace.com/forum/webcast.php.
Advertisement
About Cardiogenesis Corporation
Cardiogenesis is a medical device company specializing in the therapies for the treatment of chronic cardiac ischemia. The company's market leading Holmium:YAG laser system and disposable fiber-optic accessories are used to perform a FDA-cleared surgical procedure known as Transmyocardial Revascularization (TMR) to treat patients suffering from angina. Surgical products and accessories for the Cardiogenesis TMR procedure, which are marketed in the U.S. and around the world, have been shown to reduce angina and improve the quality of life in patients with coronary artery disease. For more information on the company and its products, please visit the Cardiogenesis website at http://www.cardiogenesis.com.
SOURCE Cardiogenesis Corporation
